Registration
MAGNET STRATEGY GROUP for MEDICAGO INC.
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Raise awareness regarding rapid response technology to better enable response to public health emergencies, including influenza and other emerging infectious diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE PETERS New | — |
Health Issues HCR
Raise awareness regarding rapid response technology to better enable response to public health emergencies, including influenza and other emerging infectious diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE PETERS New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| MITSUBISHI TANABE PHARMA | Japan | Japan | 60.0% | — |
| PHILIPMORRISINVESTMENTSB.V | Netherlands | Netherlands | 40.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.